| CASE REPORT |
|
| Year : 2015 | Volume
: 14
| Issue : 1 | Page : 51-52 |
|
|
Systemic Radiopharmaceutical Agents (Sm-153) may be Dangerous in Hepatacellular Carcinoma
Onur Keskin1, Cigdem Soydal2, Xheni Deda1, Bengu Manti1, Ali Tuzun1
1 Department of Gastroenterology, School of Medicine, Ankara University, Ankara, Turkey
2 Department of Nuclear Medicine, School of Medicine, Ankara University, Ankara, Turkey
Correspondence Address:
Onur Keskin
Department of Gastroenterology, School of Medicine, Ankara University, Ibni Sina Hospital, Ankara
Turkey
  | Check |
DOI: 10.4103/1450-1147.150548 PMID: 25709546 
|
|
|
Palliation of bone metastases in hepatocellular carcinoma (HCC) is sometimes difficult. Systemic pharmaceuticals have been successfully used for the palliation of bone metastasis for many years. Safety of these agents in HCC is not known completely. We presented a male patient with decompensated liver cirrhosis with HCC. Multifocal bone metastases developed in this patient and he had refractory bone pain. We treated this patient with Sm-153 (samarium) after obtaining patient's consent. Two days after treatment, he experienced dyspnea and we detected a massive hemorrhagic pericardial effusion. He died due to this unexpected bleeding. We should use this radiopharmaceutical treatment cautiously in these cytopenic cirrhotic patients. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Users Online: 1328 
